Inventor · disambiguated record
Marc Iglarz
Also filed as: IGLARZ MARC
3 granted patents·1 pending application·12 citations·filing 2017–2024
67Inventor score
Files withIDORSIA PHARMACEUTICALS LTD4
Top patents by PatentIndex Score
4 records- 0193US11787782B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 17, 2023·5 cites·39 claims
- 0287US11174247B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Nov 16, 2021·6 cites·47 claims
- 0378US12144811B2Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Nov 19, 2024·1 cites·31 claims
- 0471US2025120973A1Combination of a 4-pyrimidinesulfamide derivative with an sglt-2 inhibitor for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Iglarz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →